Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

3.40
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
3.37
Today|||52-Week Range
5.84
-33.33%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close3.40
Today’s open3.40
Day’s range3.37 - 3.43
Volume152,029
Average volume (3 months)18,485
Market cap$87.6M
Data as of 3:59pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-13.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-41.23%
P/E ratioNM
Price/Sales19.81
Price/Book0.99

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...0.000.00%
AXSMAxsome Therapeutics ...0.000.00%
--Wang On Group Ltd0.000.00%
PSTIPluristem Therapeuti...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.6M
Net profit margin-299.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Hamerkaz

Forecasts